FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386996270> ?p ?o ?g. }

• W4386996270 endingPage "3036" @default.
• W4386996270 startingPage "3036" @default.
• W4386996270 abstract "Primary Sjögren's syndrome (pSS) is an autoimmune disease that can cause fatigue and extraglandular manifestations (EGMs). pSS is associated with cytokine network dysregulation, which may be related to the immune-mediated destruction of exocrine glands.We determined cytokine levels and their relationship to EGMs, the European League Against Rheumatism (EULAR) Sjögren's syndrome disease activity index (ESSDAI), and fatigue in Saudi patients with pSS.This study was a cross-sectional, single-center study. We included forty-one patients and 71 controls. Serum samples were collected from random healthy people and pSS patients who were followed in the rheumatology and pulmonary clinics of King Saud University Medical City in Riyadh, Saudi Arabia. Levels of the frequently studied cytokines were measured using Luminex xMAP technology. Each ESSDAI score and EGM were recorded, and the Arabic version of the fatigue severity scale (FSS) was applied to assess fatigue. The main outcome measures were cytokine levels in pSS Saudi patients using/not using immune-suppressive medications (ISMs).Thirty-six (87.8%) patients had one or more EGMs, and the mean ESSDAI score was 9.95 ± 7.73. There was a significant decrease in TNFα and IL-21 levels in the pSS group compared to those in the control group (p = 0.034 and p < 0.001, respectively), whereas IL-12 levels were significantly elevated in the pSS group (p = 0.002). Cytokine levels in patients who used ISMs were the same as those in patients who did not use medications. Decreased IL-1β (p = 0.014), IL-2 (p = 0.035), IL-6 (p = 0.014), and IL-35 (p = 0.010) levels were observed in patients who had EGMs. Patients who had low disease activity exhibited low IL-10 (p = 0.018) and high IFN-α (p = 0.049), IFN-β (p = 0.049), IL-1β (p = 0.006), and IL-35 (p = 0.032) levels compared to patients with high disease activity. A negative association between a positive fatigue score and IL-1β (p = 0.010), IL-2 (p = 0.037), IFN-α (p = 0.025), TNFα (p = 0.030), IL-17 (p = 0.029), IL-12 (p = 0.046), and IL-21 (p = 0.005) levels was found.Cytokine profiles correlate with EGMs, ESSDAI, and fatigue. Patients with controlled disease activity have a normal cytokine profile that is similar to that of controls." @default.
• W4386996270 created "2023-09-25" @default.
• W4386996270 creator A5000418836 @default.
• W4386996270 creator A5006917903 @default.
• W4386996270 creator A5021330898 @default.
• W4386996270 creator A5035181983 @default.
• W4386996270 creator A5035448656 @default.
• W4386996270 creator A5041348140 @default.
• W4386996270 creator A5047247550 @default.
• W4386996270 creator A5055586254 @default.
• W4386996270 creator A5058414078 @default.
• W4386996270 creator A5058480608 @default.
• W4386996270 creator A5064335589 @default.
• W4386996270 creator A5071470203 @default.
• W4386996270 date "2023-09-24" @default.
• W4386996270 modified "2023-10-17" @default.
• W4386996270 title "Association of Inflammatory Cytokine Levels with Extra Glandular Manifestations, Fatigue, and Disease Activity in Primary Sjögren’s Syndrome in Saudi Patients: A Cross-Sectional Study" @default.
• W4386996270 cites W1967315497 @default.
• W4386996270 cites W1983982734 @default.
• W4386996270 cites W1992179713 @default.
• W4386996270 cites W1998629319 @default.
• W4386996270 cites W2020510817 @default.
• W4386996270 cites W2036379334 @default.
• W4386996270 cites W2057058215 @default.
• W4386996270 cites W2068439980 @default.
• W4386996270 cites W2079669971 @default.
• W4386996270 cites W2092954761 @default.
• W4386996270 cites W2100860198 @default.
• W4386996270 cites W2101453675 @default.
• W4386996270 cites W2114614830 @default.
• W4386996270 cites W2116810060 @default.
• W4386996270 cites W2123659751 @default.
• W4386996270 cites W2131678280 @default.
• W4386996270 cites W2137308839 @default.
• W4386996270 cites W2140124233 @default.
• W4386996270 cites W2152934852 @default.
• W4386996270 cites W2161370807 @default.
• W4386996270 cites W2161549227 @default.
• W4386996270 cites W2163611780 @default.
• W4386996270 cites W2224548572 @default.
• W4386996270 cites W2358606192 @default.
• W4386996270 cites W2481756613 @default.
• W4386996270 cites W2540091234 @default.
• W4386996270 cites W2582911768 @default.
• W4386996270 cites W2753954593 @default.
• W4386996270 cites W2754704394 @default.
• W4386996270 cites W2770155145 @default.
• W4386996270 cites W2808578114 @default.
• W4386996270 cites W2886090439 @default.
• W4386996270 cites W2913635089 @default.
• W4386996270 cites W2936103880 @default.
• W4386996270 cites W2990900545 @default.
• W4386996270 cites W2991369464 @default.
• W4386996270 cites W3008368974 @default.
• W4386996270 cites W3037496441 @default.
• W4386996270 cites W3048806315 @default.
• W4386996270 cites W3093253948 @default.
• W4386996270 cites W3108755116 @default.
• W4386996270 cites W3120556589 @default.
• W4386996270 cites W3144759815 @default.
• W4386996270 cites W35231455 @default.
• W4386996270 cites W4285474354 @default.
• W4386996270 cites W4296024375 @default.
• W4386996270 doi "https://doi.org/10.3390/diagnostics13193036" @default.
• W4386996270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37835779" @default.
• W4386996270 hasPublicationYear "2023" @default.
• W4386996270 type Work @default.
• W4386996270 citedByCount "0" @default.
• W4386996270 crossrefType "journal-article" @default.
• W4386996270 hasAuthorship W4386996270A5000418836 @default.
• W4386996270 hasAuthorship W4386996270A5006917903 @default.
• W4386996270 hasAuthorship W4386996270A5021330898 @default.
• W4386996270 hasAuthorship W4386996270A5035181983 @default.
• W4386996270 hasAuthorship W4386996270A5035448656 @default.
• W4386996270 hasAuthorship W4386996270A5041348140 @default.
• W4386996270 hasAuthorship W4386996270A5047247550 @default.
• W4386996270 hasAuthorship W4386996270A5055586254 @default.
• W4386996270 hasAuthorship W4386996270A5058414078 @default.
• W4386996270 hasAuthorship W4386996270A5058480608 @default.
• W4386996270 hasAuthorship W4386996270A5064335589 @default.
• W4386996270 hasAuthorship W4386996270A5071470203 @default.
• W4386996270 hasBestOaLocation W43869962701 @default.
• W4386996270 hasConcept C126322002 @default.
• W4386996270 hasConcept C142052008 @default.
• W4386996270 hasConcept C142724271 @default.
• W4386996270 hasConcept C198451711 @default.
• W4386996270 hasConcept C203014093 @default.
• W4386996270 hasConcept C2777489490 @default.
• W4386996270 hasConcept C2778690821 @default.
• W4386996270 hasConcept C2779134260 @default.
• W4386996270 hasConcept C2780194698 @default.
• W4386996270 hasConcept C71924100 @default.
• W4386996270 hasConcept C8891405 @default.
• W4386996270 hasConcept C90924648 @default.
• W4386996270 hasConceptScore W4386996270C126322002 @default.
• W4386996270 hasConceptScore W4386996270C142052008 @default.
• W4386996270 hasConceptScore W4386996270C142724271 @default.
• W4386996270 hasConceptScore W4386996270C198451711 @default.

• next